Thrivent Financial for Lutherans reduced its position in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) by 32.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 518,815 shares of the company’s stock after selling 253,871 shares during the quarter. Thrivent Financial for […]
Alliance Wealth Advisors LLC UT bought a new stake in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 6,705 shares of the company’s stock, valued at approximately $908,000. Other large […]
Regent Peak Wealth Advisors LLC grew its position in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) by 18.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,689 shares of the company’s stock after purchasing an additional 2,300 shares during […]
Beck Bode LLC purchased a new stake in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) in the 4th quarter, Holdings Channel reports. The fund purchased 4,811 shares of the company’s stock, valued at approximately $651,000. Several other hedge funds and other institutional investors have also recently made changes to their positions in NVO. […]
Parametrica Management Ltd bought a new stake in Novo Nordisk A/S (NYSE:NVO – Get Rating) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 13,900 shares of the company’s stock, valued at approximately $1,880,000. Novo Nordisk A/S accounts for about 3.9% of Parametrica Management […]